Does Rallies track congressional trades in LH?

Yes. Rallies tracks politician and congressional stock disclosures for LH, including reported purchases, sales, dates, owners, and trade amounts when available.

Is LH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LH. It does not provide personalized investment advice.

LH (Labcorp Holdings Inc.) Stock Analysis - Politician Trades

Labcorp Holdings Inc. (LH) is a publicly traded Healthcare sector company. As of May 20, 2026, LH trades at $254.87 with a market cap of $20.96B and a P/E ratio of 22.31. LH moved +0.39% today. Year to date, LH is +0.81%; over the trailing twelve months it is +1.56%. Its 52-week range spans $209.38 to $293.72. Analyst consensus is strong buy with an average price target of $310.78. Rallies surfaces LH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded LH stock?

Recent politician trading activity in LH includes disclosures from Tony Wied, April Delaney, April Delaney, April Delaney, and April Delaney. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

LH Key Metrics

Key financial metrics for LH
Metric	Value
Price	$254.87
Market Cap	$20.96B
P/E Ratio	22.31
EPS	$11.36
Dividend Yield	0.72%
52-Week High	$293.72
52-Week Low	$209.38
Volume	135.35K
Avg Volume	0
Revenue (TTM)	$14.14B
Net Income	$942.70M
Gross Margin	28.83%

Congressional Trades in LH

Tony Wied purchase LH on Feb 19, 2026 (amount: $50.00K) for Joint.
April Delaney purchase LH on Feb 11, 2026 (amount: $15.00K).
April Delaney purchase LH on Feb 4, 2026 (amount: $15.00K).
April Delaney purchase LH on Jan 28, 2026 (amount: $15.00K).
April Delaney purchase LH on Nov 17, 2025 (amount: $15.00K).

Latest LH News

Labcorp Unveils MyLabcorp AI App for Lab Results, Trend Tracking and Scheduling — May 20, 2026
Labcorp surges after Q1 beat and higher 2026 EPS guidance — Apr 30, 2026
Labcorp Q1 Revenue Up 5.8% to $3.54B, Lifts Full-Year EPS Guidance — Apr 30, 2026
Labcorp slides ahead of April 30 earnings as traders de-risk positions — Apr 23, 2026
Labcorp Launches FDA-Approved PD-L1 Test for Keytruda in Ovarian Cancer — Apr 22, 2026

Recent LH Insider Trades

Schechter Adam H sold 5.90K (~$1.50M) on May 11, 2026.
Wilkinson Peter J sold 1.63K (~$436.09K) on Mar 27, 2026.
Meltzer Jonathan C sold 839 (~$224.05K) on Mar 27, 2026.

LH Analyst Consensus

10 analysts cover LH: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $310.78.

Common questions about LH

Which politicians traded LH stock?: Recent politician trading activity in LH includes disclosures from Tony Wied, April Delaney, April Delaney, April Delaney, and April Delaney. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in LH?: Yes. Rallies tracks politician and congressional stock disclosures for LH, including reported purchases, sales, dates, owners, and trade amounts when available.
Is LH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LH. It does not provide personalized investment advice.